Nestle and POM Under Scrutiny for Health Claims

A judge ruled today in a 335-page decision that POM Wonderful, LLC did not have enough evidence to make claims that the pamagranate juice or pill could fight against heart disease, prostate cancer, or erectile dysfunction. The Federal Trade Commission filed a complaint against the company in 2010, alledging that it was making unlawful claims about its health benefits in its advertising campaigns.

Now, Reuters reports that the Nestle corporation has opened a new clinical development unit, staffed with 40 scientists, to test the health claims it makes about its products. "Our clinical development work ultimately provides the scientific evidence as to whether our ingredients, new products and reformulations are effective in delivering consumer benefits," said Werner Bauer, Nestle's technology chief, during a news conference.

Nestle hopes to sell "functional food" and eventually become "the world's leading nutrition, health and wellness company," even though it currently manufactures treats such as KitKat bars and Nesquik chocolate milk. In fact, those products bring in a lot of profit for the company.

Still, 700 scientists working in the Nestle Research Center are conducting tests and trials to see what benefits can scientifically be proven from Nestle's food.

More News
Real Time Analytics